Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008
Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008
复制标题
DOI：
10.1016/j.ypmed.2010.11.006
复制
发表时间：
2011-05-01
影响因子：
5.1
通讯作者：
Markowitz, Lauri E.
中科院分区：
文献类型：
--
作者：
Taylor, La'Shan D.;Hariri, Susan;Markowitz, Lauri E.
目标。本研究旨在根据美国 9-59 岁女性全国代表性样本获得疫苗许可后 1-2 年的人口统计和性行为特征来估计人乳头瘤病毒 (HPV) 疫苗的覆盖率。方法。 2007-2008年，共有2775名9-59岁的女性在国家健康和营养检查调查（NHANES）中回答了有关HPV疫苗接种的问题。在调整调查设计后，在双变量分析中对选定年龄类别的人口统计和性别特征进行了评估。结果。总体而言，11-26 岁女性中有 15.2% 表示已开始接种 HPV 疫苗；疫苗接种因年龄而异。我们发现，无论是 1118 岁还是 19-26 岁的人，接种疫苗的情况没有因种族或贫困程度而存在显着差异。拥有私人保险的 19-26 岁人群中接种疫苗的人数 (16.3%) 明显多于拥有公共保险的人群 (4.0%) (p = 0.04)。在 14-18 岁的女性中，有过性行为的女性 (28.6%) 的疫苗接种率高于从未有过性行为的女性 (17.8%) (p = 0.05)。结论。这些结果描述了疫苗获得许可后不久就开始接种 HPV 疫苗。 14-18 岁女性中开始接种疫苗的比例最高。应努力提高推荐年龄组的 HPV 疫苗覆盖率。由爱思唯尔公司出版
Objectives. This study aims to estimate human papillomavirus (HPV) vaccine coverage by demographic and sexual behavior characteristics 1-2 years after vaccine licensure in a nationally representative sample of females aged 9-59 years in the United States.Methods. In 2007-2008, a total of 2775 females aged 9-59 years responded to questions on HPV vaccine receipt in the National Health and Nutrition Examination Survey (NHANES). Demographic and sexual characteristics were evaluated for select age categories in bivariate analyses after adjusting for survey design.Results. Overall, 15.2% of females aged 11-26 years reported HPV vaccine initiation; vaccine initiation varied significantly by age. We found no significant difference in vaccine initiation by race or poverty level in either 1118 or 19-26-year olds. Significantly more 19-26-year olds with private insurance initiated vaccine (16.3%) than those with public insurance (4.0%) (p = 0.04). Among females aged 14-18 years, vaccine initiation was higher in those who ever had sex (28.6%) compared to those who had never had sex (17.8%) (p = 0.05).Conclusions. These results describe HPV vaccine initiation shortly after vaccine licensure. Vaccine initiation was highest in females aged 14-18 years. Efforts should be made to increase HPV vaccine coverage for the recommended age groups. Published by Elsevier Inc.